Sentinel Node Biopsy: ICG-99mTc-Nanoscan Tracer

We are studying a new hybrid tracer to improve the detection of sentinel nodes in cancer patients. This trial aims to see how well it works compared to traditional methods during preoperative imaging.

Efficacy phase (II)No PlaceboStandard MedicinesInjectionOncologyOtolaryngology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Human Albumin Solution
Human albumin solution is a blood-derived protein that restores blood volume and maintains fluid balance in those with low blood protein or severe fluid loss.
Indocyanine Green
Indocyanine Green is a diagnostic dye used to visualize blood flow and tissue perfusion during imaging and surgical procedures.
Technetium (99mtc)
Technetium-99m is a radioactive tracer that helps create images of organs and tissues for diagnosing health conditions.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Surgery
Amstelveen, Netherlands
Sponsor: Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.